Neoadjuvant Combo Beneficial in Soft Tissue Sarcoma

In soft tissue sarcomas of the trunk or extremities, a neoadjuvant chemotherapy combination of epirubicin plus ...

MARCH 29, 2017

New STS Therapy Granted Accelerated Approval

The therapy was approved in combination with doxorubicin to treat patients with soft tissue sarcoma (STS) who ...

OCTOBER 20, 2016

Neoadjuvant Chemotherapy Yields Benefits in High-Risk STS Patients

Three cycles of full-dose neoadjuvant chemotherapy with epirubicin and ifosfamide improve survival by as much as ...

OCTOBER 14, 2016

Palifosfamide Fails To Add Clinical Value to Doxorubicin for Metastatic STS

Results from an international, Phase III, randomized controlled trial have yielded disappointing findings for ...

SEPTEMBER 24, 2016

PET-CT Fails to Identify Nodal Metastases in Sarcoma

PET-CT should not be used to detect nodal metastases in patients with soft tissue sarcoma, according to a ...

AUGUST 30, 2016

Pediatric STS Response Rates Improve With Bevacizumab Plus Chemotherapy

Data presented at ASCO 2016 revealed mixed findings when bevacizumab is added to conventional chemotherapy for the ...

JULY 29, 2016

Risk for Bone and Soft-Tissue Sarcoma Varies Among Non-Sarcoma Cancer Survivors

Survivors of pediatric non-Hodgkin lymphoma and pediatric central nervous system cancers are over 10 times more ...

JULY 29, 2016

Good Outcomes With Multimodal Approach for Unresectable STS

Nearly 80% of patients with marginally inoperable soft tissue sarcoma (STS) can achieve negative surgical margins ...

JUNE 27, 2016

Time Interval From Surgery To Adjuvant RT for STS Not Critical

The time between surgery and adjuvant radiotherapy seems to make no significant difference in changing disease ...

JUNE 20, 2016